Patent ID: 9458174
Filing Date: 2016-10-04
CPC Classification: A01N,A61K,A61P,C07C,C07D

Claim Text:
1. A compound selected from the group consisting of: (a) 3-formamido-N-(heptadecan-9-yl)-2-hydroxybenzamide; (b) N-cyclopentadecyl-7-hydroxy-1H-indazole-6-carboxamide; (c) N-cyclopentadecyl-3-formamido-2-hydroxybenzamide; (d) N-cyclododecyl-3-formamido-2-hydroxybenzamide; (e) 3, 5-dichloro-N-cyclopentadecyl-2-hydroxybenzamide; (f) 3, 5-dichloro-N-decyl-2-hydroxybenzamide; (g) N-(3, 5-dichloro-2-hydroxyphenyl)undecanamide; (h) N-(4-(cyclopentadecylcarbamoyl)phenyl)-3-formamido-2-hydroxybenzamide; (i) N-(heptadecan-9-yl)-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxamide; (j) N-(3-(1-(heptadecan-9-yl)-1H-1,2,3-triazol-4-yl)-2-hydroxyphenyl)formamide; (k) N-(3-(1-cyclopentadecyl-1H-1,2,3-triazol-4-yl)-2-hydroxyphenyl)formamide; (l) N-cyclononyl-7-hydroxy-1H-indazole-6-carboxamide; (m) N-cyclononyl-2-oxo-2,3-dihydro-1H-benzo[d]imidazole-4-carboxamide; and (n) N-cyclopentadecyl-2-oxo-2, 3-dihydro-1H-benzo[d]imidazole-4-carboxamide, or a pharmaceutically acceptable salt or solvate of any one of (a)-(n).